An integrative analysis of DNA methylation, transcriptomic changes, and cognitive dysfunction in Alzheimer's disease
阿尔茨海默病 DNA 甲基化、转录组变化和认知功能障碍的综合分析
基本信息
- 批准号:9353721
- 负责人:
- 金额:$ 21.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-30 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:Aberrant DNA MethylationAlzheimer&aposs DiseaseAmyloid beta-ProteinApplications GrantsAutopsyBindingBioinformaticsBiology of AgingBiopsyBrainCellsClinicalCognitiveCollaborationsComputational TechniqueComputer AnalysisDNADNA MethylationDNA analysisDataDementiaDiseaseDoctor of PhilosophyDrainage procedureEpigenetic ProcessFreezingFutureGene ExpressionGenesGenetic TranscriptionGenomeGenomicsGoalsGrantHistologicHumanHydrocephalusImpaired cognitionKnowledgeLeadershipLinkMethodologyMethodsMethylationModificationMolecularNatureNerve DegenerationNeurodegenerative DisordersNeuropsychologyNeurosciencesNew YorkNormal Pressure HydrocephalusPathogenesisPathologicPathologyPatientsPhysiciansPlayPrincipal InvestigatorResearchResourcesRoleSamplingScientistSenile PlaquesShunt DeviceSpecificityTechniquesTimeTissuesTrainingTranslatingUniversitiesValidationWorkWritingaging brainbrain tissuecell typecognitive changecomputational neurosciencedementeddensityexperimental studyfollow-upneurosurgerypatient populationpreventprogramspromoterskillstau Proteinstooltranscription factortranscriptomics
项目摘要
Program Director/Principal Investigator (Last, First, Middle): Teich, Andrew Franklin
Project Summary:
This is a training grant that will give me the resources to develop into an academic physician-scientist. My long-
term goal is to do research that focuses on Alzheimer's disease (AD) and neurodegenerative diseases of the
aging brain, and integrate this with my clinical role as a neuropathologist (with at least 75% of my time
dedicated to research). This grant has a scientific proposal component as well as a training component. The
scientific proposal component will ask two questions. First, I will ask if there are differences in gene
methylation between AD patients and cognitively normal patients with a similar cortical β-amyloid load
(“pathological controls”). AD patients have been shown to have abnormalities in DNA methylation, and β-
amyloid has also been shown to cause alterations in DNA methylation. However, “pathologic controls” have
elevated β-amyloid levels but are not demented. Since pathologic controls have elevated β-amyloid levels, and
β-amyloid has been shown to cause altered DNA methylation, pathologic controls may have some DNA
methylation abnormalities normally associated with AD that do not directly cause dementia. By comparing AD
brain tissue to pathological control tissue, I hope to tease out changes in gene methylation that correlate
strongest with the presence of dementia. Second, I will ask whether there are changes in DNA methylation that
are predictive of worsening cognitive status in the setting of AD pathology, using a patient population that is
being shunted for hydrocephalus. In all, these experiments will help to tease out the association of abnormal
DNA methylation with impaired cognition in AD. My PhD thesis was in a computational neuroscience lab (i.e.
“dry-lab” work). I have spent the last several years after my clinical training becoming proficient in experimental
neuroscience (i.e. “wet-lab” work). This training grant will take advantage of this background and train me in
computational techniques of analyzing genomic and genome expression data, with a focus on applying these
techniques to neurodegeneration and the aging brain. In addition, this training grant is coinciding with my
elevation to Co-Director of the New York Brain Bank at Columbia University. I will accomplish four training
goals during the course of this grant; 1) Acquire a skill set to facilitate my new leadership role at Columbia, 2)
Acquire the skills to perform computational analysis of genomic and genome expression data, 3) Deepen my
knowledge of aging biology, 4) Acquire skills to succeed in writing my first R01 grant. In summary, this training
grant, through the scientific proposal and the training plan, will give me the resources to flourish as a scientist
and make a contribution to Alzheimer's disease research.
0925-0001/0002 (Rev. 08/12) Page Continuation Format Page
计划总监/首席调查员(最后,第一,中间):Teich,Andrew Franklin
项目摘要:
这是一项培训补助金,它将为我提供发展为学术身体科学家的资源。我的长期
术语目标是进行侧重于阿尔茨海默氏病(AD)和神经退行性疾病的研究
大脑衰老,并将其与我作为神经病理学家的临床角色相结合(我的时间至少有75%
致力于研究)。该赠款具有科学提案部分以及培训组成部分。这
科学提案部分将提出两个问题。首先,我会问基因是否存在差异
AD患者与具有相似皮质β-淀粉样蛋白负荷的认知正常患者之间的甲基化
(“ partiologoly Controls”)。已显示AD患者在DNA甲基化中有异常,β-
淀粉样蛋白也已显示导致DNA甲基化的改变。但是,“病理控制”具有
β-淀粉样蛋白水平升高,但不痴呆。由于病理对照的β-淀粉样蛋白水平升高,并且
β-淀粉样蛋白已显示导致DNA甲基化改变,病理控制可能具有一定的DNA
通常与不会直接引起痴呆的AD相关的甲基化异常。通过比较广告
脑组织到病理控制组织,我希望取消相关的基因甲基化的变化
痴呆症的存在最强。其次,我会问是否有DNA甲基化发生变化
可以预测在AD病理中担心认知状况,使用患者人群
被晒黑了。总之,这些实验将有助于取消异常的关联
DNA甲基化AD中的认知受损。我的博士学位论文是在计算神经科学实验室中(即
“干lab”工作)。在临床训练熟练精通实验后,我已经度过了过去几年
神经科学(即“湿地”工作)。这项培训赠款将利用这一背景,并培训我
分析的基因组和基因组表达数据的计算技术,重点是应用这些
神经变性和衰老大脑的技术。此外,这项培训赠款与我的
高程到哥伦比亚大学纽约大脑银行联合导演。我将完成四个训练
在这笔赠款过程中的目标; 1)获得一项技能,以促进我在哥伦比亚的新领导角色,2)
获取对基因组和基因组表达数据进行计算分析的技能,3)加深我
衰老生物学知识,4)获取成功撰写我的第一个R01赠款的技能。总之,这项培训
通过科学建议和培训计划,格兰特将为我提供资源,以蓬勃发展
并为阿尔茨海默氏病研究做出贡献。
0925-0001/0002(修订版08/12)页面延续格式页面
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew Franklin Teich其他文献
Andrew Franklin Teich的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew Franklin Teich', 18)}}的其他基金
A Translational Bioinformatics Approach to Rescuing Synaptic and Neurophysiologic Dysfunction in Alzheimer's Disease
挽救阿尔茨海默病突触和神经生理功能障碍的转化生物信息学方法
- 批准号:
10320653 - 财政年份:2018
- 资助金额:
$ 21.09万 - 项目类别:
A Translational Bioinformatics Approach to Rescuing Synaptic and Neurophysiologic Dysfunction in Alzheimer's Disease
挽救阿尔茨海默病突触和神经生理功能障碍的转化生物信息学方法
- 批准号:
10441481 - 财政年份:2018
- 资助金额:
$ 21.09万 - 项目类别:
A Translational Bioinformatics Approach to Rescuing Synaptic and Neurophysiologic Dysfunction in Alzheimer's Disease
挽救阿尔茨海默病突触和神经生理功能障碍的转化生物信息学方法
- 批准号:
10165445 - 财政年份:2018
- 资助金额:
$ 21.09万 - 项目类别:
A systems approach to DNA methylation, gene expression, and cognitive dysfunction in Alzheimer's disease
阿尔茨海默病 DNA 甲基化、基因表达和认知功能障碍的系统方法
- 批准号:
8869425 - 财政年份:2015
- 资助金额:
$ 21.09万 - 项目类别:
A study of ZCCHC17 regulation of synaptic genes in Alzheimers disease
ZCCHC17对阿尔茨海默病突触基因调控的研究
- 批准号:
8757603 - 财政年份:2014
- 资助金额:
$ 21.09万 - 项目类别:
Learning and Adaptation in Primary Visual Cortex
初级视觉皮层的学习和适应
- 批准号:
6790437 - 财政年份:2004
- 资助金额:
$ 21.09万 - 项目类别:
Learning and Adaptation in Primary Visual Cortex
初级视觉皮层的学习和适应
- 批准号:
6886122 - 财政年份:2004
- 资助金额:
$ 21.09万 - 项目类别:
相似海外基金
DNA methylation signatures of Alzheimer's disease in aged astrocytes
老年星形胶质细胞中阿尔茨海默病的 DNA 甲基化特征
- 批准号:
10807864 - 财政年份:2023
- 资助金额:
$ 21.09万 - 项目类别:
Enhancer RNAs in brain gene regulation and Alzheimer's disease
大脑基因调控和阿尔茨海默病中的增强子 RNA
- 批准号:
10667052 - 财政年份:2023
- 资助金额:
$ 21.09万 - 项目类别:
Development of an epigenetic clock that predicts age-impaired or age-unimpaired cognitive performance
开发表观遗传时钟来预测年龄受损或年龄未受损的认知表现
- 批准号:
10510390 - 财政年份:2022
- 资助金额:
$ 21.09万 - 项目类别:
Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection
HIV/SIV 感染中大麻素调节神经炎症的表观遗传机制
- 批准号:
10434910 - 财政年份:2020
- 资助金额:
$ 21.09万 - 项目类别:
Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection
HIV/SIV 感染中大麻素调节神经炎症的表观遗传机制
- 批准号:
10266139 - 财政年份:2020
- 资助金额:
$ 21.09万 - 项目类别: